Why Cellebrite DI Ltd.’s (CLBT) Stock Is Up 6.70%
As of Friday, November 13, Cellebrite DI Ltd.’s CLBT share price has surged by 6.70%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Michael Rose
Tudor Pop
Rosalio Madrigal
Michael Rose
| Share Statistics | CLBT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,669.6 | $924.3 | 59% |
|
| Shares Out (Mil) | 252.8 | 76.1 | 80% |
|
| Institutional Ownership | 94.9% | 82.4% | 66% |
|
| Float (Mil) | 99.1 | 54.1 | 60% |
|
| Beta | 1.01 | 1.04 | 60% |
|
| Avg Daily Volume (000s) | 3,133 | 746 | 86% |
|
| Price Change (52-week) |
(42.3%) | 56.8% | 24% |
|
| Growth | CLBT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 19.5% | 14.7% | 81% |
|
| Net Income (5yr) | 68.3% | 10.1% | 97% |
|
| EPS (5yr) | 42.5% | 15.9% | 90 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (21.7%) | (15.4%) | 30% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 8 | 8 | 8 | |
| Current EPS | $0.173 | $0.583 | $0.669 | |
| Month Ago EPS | $0.176 | $0.549 | $0.653 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $0.176 | $0.549 | $0.653 | |
| Year/Year Chg | 565.4% | 88.1% | 161.6% | |
| Financials | CLBT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $514 | $345 | 41% |
|
| Net Income (TTM) (Mil) | $59 | ($3) | 55% |
|
| EPS (TTM) | $0.237 | ($0.100) | 47% |
|
| Operating Cash Flow (TTM) (Mil) | $158 | $35 | 56% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $2 | 36% |
|
| Long-Term Debt (Q1) (Mil) | $18 | $35 | 32% |
|
| Enterprise Value (Q1) (Mil) | $3,119 | $1,077 | 55% |
|
| Valuation | CLBT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.95 | 3.00 | 81% |
|
| P/E | 46.3 | 33.1 | 86% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.1 | 1.9 | 51% |
|
| Ratios | CLBT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 82.3% | 69.9% | 90% |
|
| Net Margin | 12.1% | 1.0% | 67% |
|
| ROA | 7.6% | (2.3%) | 80% |
|
| ROE | 23.6% | 0.3% | 83% |
|
| Liabilities to Assets | 45.9% | 46.5% | 37% |
|
| F-Score | 4 | 5 | 33% |
|
Cellebrite DI Ltd. did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors